Giulia Adriani

Giulia Adriani


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2016 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
GAGiulia Adriani
Giulia Adriani
DMDongliang Ma
Dongliang Ma
APAndrea Pavesi
Andrea Pavesi
RKRoger D Kamm
Roger D Kamm
EGEyleen Goh
Eyleen Goh
The neurovascular unit is a complex, interdependent system composed of neurons and neural supporting cells, such as astrocytes, as well as cells that comprise the vascular system including endothelial cells, pericytes, and smooth muscle cells. Each cell type in the neurovascular unit plays an essential role, either in transmitting and processing neural signals or in maintaining the appropriate microenvironmental conditions for healthy neural function. In vitro neurovascular models can be useful for understanding the different roles and functions of the cells composing the neurovascular unit, as well as for assessing the effects on neural function of therapeutic compounds after crossing the endothelial barrier. Here, we report a novel three-dimensional neurovascular microfluidic model consisting of primary rat astrocytes and neurons together with human cerebral microvascular endothelial cells. These three cell types in our neurovascular chip (NVC) show distinct cell type-specific morphological characteristics and functional properties. In particular, morphological and functional analysis of neurons enables quantitative assessment of neuronal responses, while human cerebral endothelial cells form monolayers with size-selective permeability similar to existing in vitro blood–brain barrier (BBB) models.

13 May 2016 in OncoImmunology
Verified
Journal Article
Open access
HPHweixian Leong Penny
Hweixian Leong Penny
JSJe Lin Sieow
Je Lin Sieow
GAGiulia Adriani
Giulia Adriani
WYWei Hseun Yeap
Wei Hseun Yeap
PEPeter See Chi Ee
Peter See Chi Ee
SWSiew Cheng Wong
Siew Cheng Wong
Patients with pancreatic ductal adenocarcinoma (PDAC) face a clinically intractable disease with poor survival rates, attributed to exceptionally high levels of metastasis. Epithelial-to-mesenchymal transition (EMT) is pronounced at inflammatory foci within the tumor; however, the immunological mechanisms promoting tumor dissemination remain unclear. It is well established that tumors exhibit the Warburg effect, a preferential use of glycolysis for energy production, even in the presence of oxygen, to support rapid growth. We hypothesized that the metabolic pathways utilized by tumor-infiltrating macrophages are altered in PDAC, conferring a pro-metastatic phenotype. We generated tumor-conditioned macrophages in vitro, in which human peripheral blood monocytes were cultured with conditioned media generated from normal pancreatic or PDAC cell lines to obtain steady-state and tumor-associated macrophages (TAMs), respectively. Compared with steady-state macrophages, TAMs promoted vascular network formation, augmented extravasation of tumor cells out of blood vessels, and induced higher levels of EMT. TAMs exhibited a pronounced glycolytic signature in a metabolic flux assay, corresponding with elevated glycolytic gene transcript levels. Inhibiting glycolysis in TAMs with a competitive inhibitor to Hexokinase II (HK2), 2-deoxyglucose (2DG), was sufficient to disrupt this pro-metastatic phenotype, reversing the observed increases in TAM-supported angiogenesis, extravasation, and EMT. Our results indicate a key role for metabolic reprogramming of tumor-infiltrating macrophages in PDAC metastasis, and highlight the therapeutic potential of using pharmacologics to modulate these metabolic pathways.

15 June 2017 in JCI Insight
Verified
Journal Article
Open access
PDF file
APAndrea Pavesi
Andrea Pavesi
ATAnthony T. Tan
Anthony T. Tan
SKSarene Koh
Sarene Koh
ACAdeline Chia
Adeline Chia
MCMarta Colombo
Marta Colombo
ABAntonio Bertoletti
Antonio Bertoletti
The tumor microenvironment imposes physical and functional constraints on the antitumor efficacy of adoptive T cell immunotherapy. Preclinical testing of different T cell preparations can help in the selection of efficient immune therapies, but in vivo models are expensive and cumbersome to develop, while classical in vitro 2D models cannot recapitulate the spatiotemporal dynamics experienced by T cells targeting cancer. Here, we describe an easily customizable 3D model, in which the tumor microenvironment conditions are modulated and the functionality of different T cell preparations is tested. We incorporate human cancer hepatocytes as a single cell or as tumor cell aggregates in a 3D collagen gel region of a microfluidic device. Human T cells engineered to express tumor-specific T cell receptors (TCR–T cells) are then added in adjacent channels. The TCR–T cells’ ability to migrate and kill the tumor target and the profile of soluble factors were investigated under conditions of varying oxygen levels and in the presence of inflammatory cytokines. We show that only the 3D model detects the effect that oxygen levels and the inflammatory environment impose on engineered TCR–T cell function, and we also used the 3D microdevice to analyze the TCR–T cell efficacy in an immunosuppressive scenario. Hence, we show that our microdevice platform enables us to decipher the factors that can alter T cell function in 3D and can serve as a preclinical assay to tailor the most efficient immunotherapy configuration for a specific therapeutic goal.

1 February 2012 in Journal of Controlled Release
Verified
Journal Article
Closed access
AVAnne L. van de Ven
Anne L. van de Ven
PKPilhan Kim
Pilhan Kim
OHO'HAra Haley
O'HAra Haley
JFJean R. Fakhoury
Jean R. Fakhoury
GAGiulia Adriani
Giulia Adriani
Paolo DecuzziPaolo Decuzzi
Paolo Decuzzi

1 August 2012 in Biomaterials
Verified
Journal Article
Closed access
GAGiulia Adriani
Giulia Adriani
MTMarco Donato de Tullio
Marco Donato de Tullio
MFMauro Ferrari
Mauro Ferrari
FHFazle Hussain
Fazle Hussain
Giuseppe PascazioGiuseppe Pascazio
Giuseppe Pascazio
Paolo DecuzziPaolo Decuzzi
Paolo Decuzzi

2 July 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
APAndrea Pavesi
Andrea Pavesi
GAGiulia Adriani
Giulia Adriani
MRMarco Rasponi
Marco Rasponi
IZIoannis K. Zervantonakis
Ioannis K. Zervantonakis
GFGianfranco B. Fiore
Gianfranco B. Fiore
RKRoger D Kamm
Roger D Kamm
Stem cell research has yielded promising advances in regenerative medicine, but standard assays generally lack the ability to combine different cell stimulations with rapid sample processing and precise fluid control. In this work, we describe the design and fabrication of a micro-scale cell stimulator capable of simultaneously providing mechanical, electrical and biochemical stimulation and subsequently extracting detailed morphological and gene-expression analysis on the cellular response. This micro-device offers the opportunity to overcome previous limitations and recreate critical elements of the in vivo microenvironment in order to investigate cellular responses to three different stimulations. The platform was validated in experiments using human bone marrow mesenchymal stem cells. These experiments demonstrated the ability for inducing changes in cell morphology, cytoskeletal fiber orientation and changes in gene expression under physiological stimuli. This novel bioengineering approach can be readily applied to various studies, especially in the fields of stem cell biology and regenerative medicine.